http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 28 Oct 2025 21:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html <p>TOKYO, Oct 29, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which combines Narrow Band Imaging (NBI(TM) mode) and Texture and Color Enhancement Imaging (TXI(TM) mode) into a single view. Sales of the EVIS X1(TM) endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.</p><p>Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with http://www.streetinsider.com/Press+Releases/Olympus+Introduces+NBI%2BTXI%28TM%29+Observation+Mode+to+the+EVIS+X1%28TM%29+Endoscopy+System+CV-1500+Video+System+Center/25523046.html Tue, 28 Oct 2025 21:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html <p>TOKYO &amp; HAMBURG, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of THUNDERBEAT(TM) II, the next generation hybrid energy device for soft tissue management, designed to deliver faster, more hemostatic dissection and large vessel transection[1] in both laparoscopic and open surgery. THUNDERBEAT(TM) II will become commercially available in Europe starting October 2025, with a subsequent launch in Japan later this year. A global rollout, including the United States and other regions, will follow, subject to regulatory approvals including http://www.streetinsider.com/Press+Releases/Olympus+Launches+New+Surgical+Energy+Device+for+Hemostatic+Cutting+and+Vessel+Sealing/25480665.html Tue, 21 Oct 2025 09:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html <p>TOKYO, Oct 21, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), today announced that the feasibility study project entitled &quot;Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,&quot; jointly proposed with Saraya Co., Ltd. (hereinafter &quot;SARAYA&quot;), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary &quot;Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)&quot; on August 1, 2025.</p><p>The selected feasibility study project (hereinafter the &quot;Project&quot;), supported by METI, will evaluate the feasibility of introducing Japan&apos;s established infection control systems to India, aiming to enhance the http://www.streetinsider.com/Press+Releases/Olympus%3A+%26quot%3BFeasibility+study+on+the+development+of+Japanese+digitalized+endoscopy+infection+control+systems+in+India%26quot%3B+Selected+for+METI%26apos%3Bs+FY2024+Supplementary+%26quot%3BGlobal+South+Future-O/25477724.html Mon, 20 Oct 2025 21:00:00 -0500 7733 A.14832576 A.30084520 O.04956817 O.05105669 O.05421017 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+SecureFlex%2C+a+Single-use+Fine+Needle+Biopsy+Device/25420617.html <p>TOKYO &amp; HAMBURG, Oct 6, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of SecureFlex, a single-use fine needle biopsy device. SecureFlex will be commercially available in Europe and Japan in Autumn 2025, with a subsequent global rollout subject to regulatory requirements such as product registration and market clearance.</p><p>Designed for use with an ultrasound endoscope, SecureFlex supports endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) of submucosal and extramural lesions within the gastrointestinal tract. Its primary clinical application is in the diagnosis http://www.streetinsider.com/Press+Releases/Olympus+Launches+SecureFlex%2C+a+Single-use+Fine+Needle+Biopsy+Device/25420617.html Mon, 06 Oct 2025 01:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY http://www.streetinsider.com/Press+Releases/Olympus+Launches+SecureFlex%2C+a+Single-use+Fine+Needle+Biopsy+Device/25420617.html <p>TOKYO &amp; HAMBURG, Oct 6, 2025 - (JCN Newswire) - - Olympus Corporation (Olympus), a global MedTech company committed to making people&apos;s lives healthier, safer and more fulfilling, today announced the launch of SecureFlex, a single-use fine needle biopsy device. SecureFlex will be commercially available in Europe and Japan in Autumn 2025, with a subsequent global rollout subject to regulatory requirements such as product registration and market clearance.</p><p>Designed for use with an ultrasound endoscope, SecureFlex supports endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) of submucosal and extramural lesions within the gastrointestinal tract. Its primary clinical application is in the diagnosis http://www.streetinsider.com/Press+Releases/Olympus+Launches+SecureFlex%2C+a+Single-use+Fine+Needle+Biopsy+Device/25420617.html Mon, 06 Oct 2025 01:00:00 -0500 7733 A.32657771 O.01150339 O.05105669 OCPNF OLY1 OLYMY